No Detail Found!

Prophylactic use of Topical Levobunolol in Prevention of Intraocular Pressure Elevation after Neodymium-yttrium- Aluminum-garnet (Nd: Yag) Laser Posterior Capsulotomy.

Author(s)
Muhammad Imran Ali College of Medicine, Majmaah University, Kingdom of Saudi Arabia
Ali Faraz College of Medicine, Majmaah University, Kingdom of Saudi Arabia
Muhammad Asad Farhan College of Medicine, Majmaah University, Kingdom of Saudi Arabia
Abstract
OBJECTIVE: To determine the efficacy of 0.5% levobunolol in preventing acute rise in intraocular pressure after Neodymium-YttriumAluminium-Garnet (Nd: YAG) laser posterior capsulotomy. STUDY DESIGN: A Quasi experimental study. PLACE AND DURATION: Department of Ophthalmology, Sir Ganga Ram Hospital, Lahore. One year from 1st August 2006 to 31st July 2007. METHODOLOGY: Sixty patients were selected and randomly divided into two equal groups (A and B). One hour before capsulotomy, in group A patients, one drop of 0.5% levobunolol was instilled whereas in group B, patients received one drop of placebo drug (polyvinyl alcohol 1.4% with povidone 0.6%). Immediately after capsulotomy, these drugs were repeated. The IOP was measured 1, 3 and 24 hours postoperatively and at the end of first week. RESULTS: In the levobunolol group (group A), the mean Intra ocular pressure after one hour and three hours was significantly lower (P=0.001) than in the placebo group (group B). After 24 hours and after one week there was no statistically significant difference (P>0.05) in the mean intra ocular pressure, of the two groups. CONCLUSION: 0.5% levobunolol, given prophylactically, is an effective drug for acute intra ocular pressure rise following Nd: YAG laser posterior capsulotomy.
Publication Details
Page(s) 297-300
DOI DOI not available
Published Journal: Isra Medical Journal, Volume: 9, Issue: 5, Year: 2017

Request the full text from PASTIC

References
The foundation of the American Academy of Ophthalmology. Basic and clinical science course,Section 65 169 -77
SinhaR,ShekharH,SharmaN,TitiyalJS,VajpayeeRB, 2013.Posterior capsular opacification: A review,Indian J Ophthalmol 61 371 -76
KurosakaD,KatoK,KurosakaH,YoshinoM,NakamuraK,NegishiK., 2002.Elschnig pearl formation along Nd: YAG laser posterior capsulotomy margin, long term follow up,J Cataract Refract Surg 28 1809 -13
KarahanE,ErD,KaynakS., 2014.An Overview of Nd: YAG Laser Capsulotomy,Med Hypothesis Discov Innov Ophthalmol 3 45 -50
PatilMS,BalwirDN,Vidhate S, .A Study of Nd:YAG Laser Capsulotomy in the Management of Posterior Capsular Opacification,MVP J Med Sci. 2016 3 18 -24
KarahanE,TuncerI,ZenginMO,MacularThickness, 2014.The Effect of ND:YAG Laser Posterior Capsulotomy Size on Refraction, Intraocular Pressure, and,J Ophthalmol -
GeorgalasI,PetrouP,Papaconstantinou D , Koutsandrea,C, 2009.Nd: YAG capsulotomy for posterior capsule opacification after combined clear corneal phacoemulsification and vitrectomy Ther Clin Risk Manag, 5 133 -37
HabibM,AkramA,FarooqO, 2015.Comparison of levobunolol and brimonidine in prophylaxis of intraocular pressure (iop) rise following nd:yag laser capsulotomy,Pak Armed Forces Med J 65 348 -52
AwanAA,KazmiSH,BukhariSA, 2001.Intraocular pressure changes after Nd-YAG laser capsulotomy,J Ayub Med Coll Abbottabad 13 3 -4
LatifE,KhalidM,AaqilM,AasiNA, 1999.Use of topical apraclonidine to prevent intraocular pressure elevation following Nd:YAG laser posterior capsulotomy,Pak J Ophthalmol 15 108 -12
LadasID,BaltatzisS,PanagiotidisD,ZafirakisP,KokolakisSN,TheodossiadisGP, 1997.Topical 2.0 % dorzolamaide vs oral acetazolamide for prevention of intraocular pressure rise after Neodymium:YAG laser posterior capsulotomy,Arch Ophthalmol 115 1241 -44
0

Citations

0

Downloads

32

Views